Thrive Capital Management (Pennsylvania)’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.8M Buy
25,658
+9,515
+59% +$1.75M 0.9% 37
2026
Q1
$3.05M Sell
16,143
-852
-5% -$180K 0.67% 75
2025
Q4
$3.38M Buy
16,995
+4,578
+37% +$925K 0.75% 70
2025
Q3
$2.52M Buy
12,417
+1,259
+11% +$223K 0.65% 63
2025
Q2
$1.96M Buy
11,158
+6,925
+164% +$1.04M 0.62% 69
2025
Q1
$569K Buy
+4,233
New +$557K 0.34% 66

Other funds holding THC

Thrive Capital Management (Pennsylvania)'s THC Position: Q2 2026 in Review

Thrive Capital Management (Pennsylvania) increased its Tenet Healthcare (THC) stake by 59% in Q2 2026, buying an estimated $1.75M and bringing the position to 25,658 shares worth $4.8M. The position accounts for 0.9% of the portfolio, ranked #37.

Thrive Capital Management (Pennsylvania) first reported a position in THC in Q1 2025 and has held it in 6 quarters since. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Thrive Capital Management (Pennsylvania) held 25,658 shares of Tenet Healthcare worth $4.8M as of Q2 2026.
  • Thrive Capital Management (Pennsylvania) bought 9,515 Tenet Healthcare shares in Q2 2026, an estimated $1.75M.
  • Tenet Healthcare made up 0.9% of Thrive Capital Management (Pennsylvania)'s portfolio in Q2 2026, its #37 holding.
  • Thrive Capital Management (Pennsylvania) first reported a position in Tenet Healthcare in Q1 2025 and has held it in 6 quarters since.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q2 2026, filed 5 Aug 2026.